[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.120.181. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Commentary
September 12, 2007

Limitations of Applying Summary Results of Clinical Trials to Individual PatientsThe Need for Risk Stratification

Author Affiliations
 

Author Affiliations: Institute for Clinical Research and Health Policy Studies, Tufts-New England Medical Center, Boston, Massachusetts (Dr Kent); and Veterans Affairs Ann Arbor Health Services Research and Development Service Center of Excellence and Department of Internal Medicine, University of Michigan, Ann Arbor (Dr Hayward).

JAMA. 2007;298(10):1209-1212. doi:10.1001/jama.298.10.1209

There is growing awareness that the results of randomized clinical trials might not apply in a straightforward way to individual patients, even those within the trial. Although randomization theoretically ensures the comparability of treatment groups overall, there remain important differences between individuals in each treatment group that can dramatically affect the likelihood of benefiting from or being harmed by a therapy.14 Averaging effects across such different patients can give misleading results to physicians who care for individual, not average, patients.

First Page Preview View Large
First page PDF preview
First page PDF preview
×